BHARAT Stock Today

Equity ratings for BHARAT IMMUNOLOGICALS BIOLOG are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2021 and ending today, the 18th of June 2021. Click here to learn more.
BHARAT IMMUNOLOGICALS BIOLOG cannot be verified against its exchange. It appears that BHARAT IMMUNOLOGICALS is not available for investing at the moment. Please verify the symbol is currently traded on Bombay Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

BHARAT IMMUNOLOGICALS Stock Profile

Bharat Immunologicals Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals products in India. The company was founded in 1989 and is based in Bulandshahr, India. BHARAT IMMUNOLOGICALS operates under Biotechnology classification in India and is traded on Bombay Stock Exchange.. The public information regarding BHARAT IMMUNOLOGICALS BIOLOG's current market price is not available at this time.
BHARAT IMMUNOLOGICALS is not yet fully synchronised with the market data
BHARAT IMMUNOLOGICALS has some characteristics of a very speculative penny stock
The company reported the revenue of 836.45 M. Net Loss for the year was (55.57 M) with profit before overhead, payroll, taxes, and interest of 103.65 M.
Legal NameBHARAT IMMUNOLOGICALS BIOLOG
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of BHARAT IMMUNOLOGICALS's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
BHARAT IMMUNOLOGICALS BIOLOG (BIBCL) is traded on Bombay Stock Exchange in India and employs 5 people. The company currently falls under 'Small-Cap' category with current market capitalization of 252.17 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BHARAT IMMUNOLOGICALS's market, we take the total number of its shares issued and multiply it by BHARAT IMMUNOLOGICALS's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. BHARAT IMMUNOLOGICALS operates under Healthcare sector and is part of Biotechnology industry. The entity has 43.18 M outstanding shares.
Check BHARAT IMMUNOLOGICALS Probability Of Bankruptcy

BHARAT Stock Against Markets

Picking the right benchmark for BHARAT IMMUNOLOGICALS stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in BHARAT IMMUNOLOGICALS stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for BHARAT IMMUNOLOGICALS is critical whether you are bullish or bearish towards BHARAT IMMUNOLOGICALS BIOLOG at a given time.
BHARAT IMMUNOLOGICALS BIOLOG cannot be verified against its exchange. It appears that BHARAT IMMUNOLOGICALS is not available for investing at the moment. Please verify the symbol is currently traded on Bombay Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BHARAT IMMUNOLOGICALS stock to make a market-neutral strategy. Peer analysis of BHARAT IMMUNOLOGICALS could also be used in its relative valuation, which is a method of valuing BHARAT IMMUNOLOGICALS by comparing valuation metrics with similar companies.
Check out Trending Equities. Note that the BHARAT IMMUNOLOGICALS information on this page should be used as a complementary analysis to other BHARAT IMMUNOLOGICALS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Tools for BHARAT IMMUNOLOGICALS Stock

When running BHARAT IMMUNOLOGICALS price analysis, check to measure BHARAT IMMUNOLOGICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BHARAT IMMUNOLOGICALS is operating at the current time. Most of BHARAT IMMUNOLOGICALS's value examination focuses on studying past and present price action to predict the probability of BHARAT IMMUNOLOGICALS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BHARAT IMMUNOLOGICALS's price. Additionally, you may evaluate how the addition of BHARAT IMMUNOLOGICALS to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go